Universal-Beteiligungs- und Servicegesellschaft’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$82.3K Hold
14,192
﹤0.01% 2031
2025
Q4
$111K Buy
14,192
+1,037
+8% +$8.16K ﹤0.01% 2021
2025
Q3
$107K Buy
+13,155
New +$87.4K ﹤0.01% 2053

Other funds holding XERS

Universal-Beteiligungs- und Servicegesellschaft's XERS Position: Q1 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft held its Xeris Biopharma Holdings (XERS) position steady in Q1 2026 at 14,192 shares worth $82.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2031.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in XERS in Q3 2025 and has held it in 3 quarters since. The position peaked at $111K in Q4 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 14,192 shares of Xeris Biopharma Holdings worth $82.3K as of Q1 2026.
  • Universal-Beteiligungs- und Servicegesellschaft left its Xeris Biopharma Holdings share count unchanged in Q1 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q1 2026, its #2031 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Xeris Biopharma Holdings in Q3 2025 and has held it in 3 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Xeris Biopharma Holdings position peaked at $111K in Q4 2025.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q1 2026, filed 11 May 2026.